Literature DB >> 33124202

Single-cell transcriptome analysis of tumor-infiltrating B cells reveals their clinical implications in non-small cell lung cancer.

Xia-Yao Diao1, Fang Wang2,3.   

Abstract

Entities:  

Year:  2020        PMID： 33124202      PMCID： PMC7779189          DOI： 10.1111/1759-7714.13719

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN： 1759-7706            Impact factor:   3.500


× No keyword cloud information.
  15 in total

1.  B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion.

Authors:  E Barbera-Guillem; M B Nelson; B Barr; J K Nyhus; K F May; L Feng; J W Sampsel
Journal:  Cancer Immunol Immunother       Date:  2000-01       Impact factor: 6.968

2.  Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

Authors:  Patrick M Forde; Jamie E Chaft; Kellie N Smith; Valsamo Anagnostou; Tricia R Cottrell; Matthew D Hellmann; Marianna Zahurak; Stephen C Yang; David R Jones; Stephen Broderick; Richard J Battafarano; Moises J Velez; Natasha Rekhtman; Zachary Olah; Jarushka Naidoo; Kristen A Marrone; Franco Verde; Haidan Guo; Jiajia Zhang; Justina X Caushi; Hok Yee Chan; John-William Sidhom; Robert B Scharpf; James White; Edward Gabrielson; Hao Wang; Gary L Rosner; Valerie Rusch; Jedd D Wolchok; Taha Merghoub; Janis M Taube; Victor E Velculescu; Suzanne L Topalian; Julie R Brahmer; Drew M Pardoll
Journal:  N Engl J Med       Date:  2018-04-16       Impact factor: 91.245

3.  Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Authors:  Roy S Herbst; Paul Baas; Dong-Wan Kim; Enriqueta Felip; José L Pérez-Gracia; Ji-Youn Han; Julian Molina; Joo-Hang Kim; Catherine Dubos Arvis; Myung-Ju Ahn; Margarita Majem; Mary J Fidler; Gilberto de Castro; Marcelo Garrido; Gregory M Lubiniecki; Yue Shentu; Ellie Im; Marisa Dolled-Filhart; Edward B Garon
Journal:  Lancet       Date:  2015-12-19       Impact factor: 79.321

4.  B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.

Authors:  David J DiLillo; Koichi Yanaba; Thomas F Tedder
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

5.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

6.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

7.  Acute and rapid degradation of endogenous proteins by Trim-Away.

Authors:  Dean Clift; Chun So; William A McEwan; Leo C James; Melina Schuh
Journal:  Nat Protoc       Date:  2018-10       Impact factor: 13.491

Review 8.  Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.

Authors:  Jean-François Rossi; Patrice Céballos; Zhao-Yang Lu
Journal:  Cancer Commun (Lond)       Date:  2019-06-14

Review 9.  Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.

Authors:  Tong Wu; Xuan Wu; Hong-Yang Wang; Lei Chen
Journal:  Cancer Commun (Lond)       Date:  2019-04-18

Review 10.  Precision medicine becomes reality-tumor type-agnostic therapy.

Authors:  Li Yan; Wei Zhang
Journal:  Cancer Commun (Lond)       Date:  2018-03-31
View more
  1 in total

1.  High expression of glycolysis-related PGM2 gene in relation to poor prognosis and deficient immune cells infiltration in lung adenocarcinoma: a study based on bioinformatics analysis.

Authors:  Haoda Yu; Zhen Yu; Chu Qin; Tao Bian; Minhua Shi
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.